Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 4, 2011, Pages 1758-1760

  Folster, Jason P ^a,b   Pecic, Gary ^a,b   Bowen, Anna ^a   Rickert, Regan ^a   Carattoli, Alessandra ^c   Whichard, Jean M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Ihrc Inc   (United States)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; MACROLIDE; NALIDIXIC ACID; PROTEIN PARC;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; GENE MUTATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; SHIGELLA; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SOUTH ASIA; SOUTHEAST ASIA; UNITED STATES;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; PLASMIDS; SHIGELLA; UNITED STATES;

EID: 79953168410     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01463-10     Document Type: Article

References (21)

1. American Academy of Pediatrics. 2009. Shigella infections. In L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long (ed.), Red Book: 2009 report of the Committee on Infectious Diseases, 28th ed., vol. 2009. American Academy of Pediatrics, Elk Grove Village, IL.
2. Carattoli, A., et al. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. (Pubitemid 41597366)
3. Cavaco, L. M., H. Hasman, S. Xia, and F. M. Aarestrup. 2009. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob. Agents Chemother. 53:603-608.
4. Dutta, S., P. Dutta, S. Matsushita, S. K. Bhattacharya, and S. Yoshida. 2003. Shigella dysenteriae serotype 1, Kolkata, India. Emerg. Infect. Dis. 9:1471-1474.
5. Dutta, S., et al. 2005. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India. Antimicrob. Agents Chemother. 49:1660-1661.
6. Folster, J. P., et al. 2010. Characterization of extended-spectrum cephalosporin- resistant Salmonella enterica serovar Heidelberg isolated from humans in the United States. Foodborne Pathog. Dis. 7:181-187.
7. Garcia-Fernandez, A., D. Fortini, K. Veldman, D. Mevius, and A. Carattoli. 2009. Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella. J. Antimicrob. Chemother. 63:274-281.
8. Guerrant, R. L., et al. 2001. Practice guidelines for the management of infectious diarrhea. Clin. Infect. Dis. 32:331-351.
9. Hammerl, J. A., et al. 2010. pSGI15, a small ColE-like qnrB19 plasmid of a Salmonella enterica serovar Typhimurium strain carrying Salmonella genomic island 1 (SGI1). J. Antimicrob. Chemother. 65:173-175.
10. Martinez-Martinez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799.
11. Mensa, L., F. Marco, J. Vila, J. Gascon, and J. Ruiz. 2008. Quinolone resistance among Shigella spp. isolated from travellers returning from India. Clin. Microbiol. Infect. 14:279-281.
12. Niyogi, S. K. 2005. Shigellosis. J. Microbiol. 43:133-143. (Pubitemid 40720615)
13. Pallecchi, L., et al. 2010. Characterization of small ColE-like plasmids mediating widespread dissemination of the qnrB19 gene in commensal enterobacteria. Antimicrob. Agents Chemother. 54:678-682.
14. Perichon, B., P. Courvalin, and M. Galimand. 2007. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob. Agents Chemother. 51:2464-2469.
15. Pu, X. Y., et al. 2009. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J. Antimicrob. Chemother. 63:917-920.
16. Ram, P. K., J. A. Crump, S. K. Gupta, M. A. Miller, and E. D. Mintz. 2008. Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005. Epidemiol. Infect. 136:577-603.
17. Replogle, M. L., D. W. Fleming, and P. R. Cieslak. 2000. Emergence of antimicrobial-resistant shigellosis in Oregon. Clin. Infect. Dis. 30:515-519.
18. Robicsek, A., et al. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88.
19. Robicsek, A., J. Strahilevitz, D. F. Sahm, G. A. Jacoby, and D. C. Hooper. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874.
20. Sivapalasingam, S., et al. 2006. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob. Agents Chemother. 50:49-54. (Pubitemid 43042901)
21. Wong, M. R., et al. 2010. Antimicrobial resistance trends of Shigella serotypes in New York City, 2006-2009. Microb. Drug Resist 16:155-161.